These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 38823494)
1. Dynamic evolution of ceftazidime-avibactam resistance from a single patient through the IncX3_NDM-5 plasmid transfer and bla Tang C; Shen S; Yang W; Shi Q; Ding L; Han R; Hu F Int J Antimicrob Agents; 2024 Aug; 64(2):107228. PubMed ID: 38823494 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of ceftazidime/avibactam and plazomicin on carbapenem-resistant Klebsiella pneumoniae and Escherichia coli. Öztaş S; Er DK; Dündar D; Keçeli SA Acta Microbiol Immunol Hung; 2024 Jul; 71(2):110-120. PubMed ID: 38837219 [TBL] [Abstract][Full Text] [Related]
3. Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne Shields RK; Chen L; Cheng S; Chavda KD; Press EG; Snyder A; Pandey R; Doi Y; Kreiswirth BN; Nguyen MH; Clancy CJ Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031201 [TBL] [Abstract][Full Text] [Related]
4. Emergence of ceftazidime-avibactam resistance in bla Zhou J; Yan G; Tang C; Liu J; Fu P; Ding L; Yang W; Guo Y; Wang C; Lu G; Hu F Int J Antimicrob Agents; 2024 Jun; 63(6):107163. PubMed ID: 38570018 [TBL] [Abstract][Full Text] [Related]
5. Molecular Mechanisms Driving the Li X; Ke H; Wu W; Tu Y; Zhou H; Yu Y mSphere; 2021 Dec; 6(6):e0085921. PubMed ID: 34935448 [TBL] [Abstract][Full Text] [Related]
6. Tracking emergence and outbreak of Klebsiella pneumoniae co-producing NDM-1 and KPC-2 after sulfamethoxazole-trimethoprim treatment: Insights from genetic analysis. Wang M; Hao M; Cui X; Liu M; Zhang C; Wang S Int J Antimicrob Agents; 2024 Aug; 64(2):107237. PubMed ID: 38851461 [TBL] [Abstract][Full Text] [Related]
7. Molecular characterization of carbapenem and ceftazidime-avibactam-resistant Enterobacterales and horizontal spread of Sobh G; Araj GF; Finianos M; Sourenian T; Hrabak J; Pappagianitsis CC; Chaar ME; Bitar I Front Cell Infect Microbiol; 2024; 14():1407246. PubMed ID: 38962322 [TBL] [Abstract][Full Text] [Related]
8. Ceftazidime-avibactam activity against a challenge set of carbapenem-resistant Enterobacterales: Ompk36 L3 alterations and β-lactamases with ceftazidime hydrolytic activity lead to elevated MIC values. Castanheira M; Doyle TB; Hubler C; Sader HS; Mendes RE Int J Antimicrob Agents; 2020 Jul; 56(1):106011. PubMed ID: 32417206 [TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms responsible KPC-135-mediated resistance to ceftazidime-avibactam in ST11-K47 hypervirulent Shi Q; Shen S; Tang C; Ding L; Guo Y; Yang Y; Wu S; Han R; Yin D; Hu F Emerg Microbes Infect; 2024 Dec; 13(1):2361007. PubMed ID: 38801099 [TBL] [Abstract][Full Text] [Related]
10. Dissemination and Stability of the Zhu W; Wang X; Qin J; Liang W; Shen Z mSphere; 2020 Nov; 5(6):. PubMed ID: 33148824 [TBL] [Abstract][Full Text] [Related]
11. Acquisition of a Stable and Transferable Huang J; Zhang S; Zhao Z; Chen M; Cao Y; Li B Front Cell Infect Microbiol; 2021; 11():658070. PubMed ID: 34354959 [TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase-producing Zhang W; Guo Y; Li J; Zhang Y; Yang Y; Dong D; Zhu D; He P; Hu F Antimicrob Resist Infect Control; 2018; 7():142. PubMed ID: 30479755 [TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of clinical isolates of ceftazidime-avibactam-resistant Klebsiella pneumoniae. Venditti C; Butera O; Meledandri M; Balice MP; Cocciolillo GC; Fontana C; D'Arezzo S; De Giuli C; Antonini M; Capone A; Messina F; Nisii C; Di Caro A Clin Microbiol Infect; 2021 Jul; 27(7):1040.e1-1040.e6. PubMed ID: 33775814 [TBL] [Abstract][Full Text] [Related]
14. Dynamic evolution of imipenem/relebactam resistance in a KPC-producing Klebsiella pneumoniae from a single patient during ceftazidime/avibactam-based treatments. Gaibani P; Bovo F; Bussini L; Lazzarotto T; Amadesi S; Bartoletti M; Viale P; Ambretti S J Antimicrob Chemother; 2022 May; 77(6):1570-1577. PubMed ID: 35373297 [TBL] [Abstract][Full Text] [Related]
15. Successive Emergence of Ceftazidime-Avibactam Resistance through Distinct Genomic Adaptations in Giddins MJ; Macesic N; Annavajhala MK; Stump S; Khan S; McConville TH; Mehta M; Gomez-Simmonds A; Uhlemann AC Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263067 [TBL] [Abstract][Full Text] [Related]
16. Spread and evolution of bla Yang W; Tang C; Shen S; Shi Q; Hu F Int J Antimicrob Agents; 2024 May; 63(5):107149. PubMed ID: 38508537 [TBL] [Abstract][Full Text] [Related]